المؤلفون: Qi J; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Choi I; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan., Ota S; Sapporo Hokuyu Hospital, Sapporo, Japan., Ichikawa S; Tohoku University Hospital, Sendai, Japan., Fujishima N; Noshiro Kousei Medical Center, Akita, Japan., Iida H; National Hospital Organization Nagoya Medical Center, Nagoya, Japan., Sugiura I; Toyohashi Hematology Oncology Clinic, Aichi, Japan., Sugiura K; Daiichi Sankyo Co., Ltd, Tokyo, Japan., Murata Y; Daiichi Sankyo Co., Ltd, Tokyo, Japan., Inoue H; Daiichi Sankyo Co., Ltd, Tokyo, Japan., Ohwada S; Daiichi Sankyo Co., Ltd, Tokyo, Japan., Wang J; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

المصدر: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 May; Vol. 13 (5), pp. 560-571. Date of Electronic Publication: 2024 Jan 29.

نوع المنشور: Journal Article; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't; Multicenter Study

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Phenylurea Compounds*/administration & dosage , Phenylurea Compounds*/pharmacokinetics , Phenylurea Compounds*/adverse effects , Benzothiazoles*/adverse effects , Benzothiazoles*/pharmacokinetics , Benzothiazoles*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/pharmacokinetics , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , fms-Like Tyrosine Kinase 3*/antagonists & inhibitors , Consolidation Chemotherapy*/adverse effects , Consolidation Chemotherapy*/methods, Humans ; Male ; Middle Aged ; Female ; China ; Adult ; Japan ; Aged ; Induction Chemotherapy/methods ; Dose-Response Relationship, Drug

المؤلفون: Kim YR; Division of Hematology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea., Cho H; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea., Kim SJ; Division of Hemato-Oncology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea., Chung H; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea., Kook HW; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea., Jang JE; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea., Cheong JW; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea., Kim JS; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.

المصدر: The oncologist [Oncologist] 2024 Jun 03; Vol. 29 (6), pp. e796-e802.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Etoposide*/administration & dosage , Etoposide*/therapeutic use , Etoposide*/adverse effects , Cytarabine*/administration & dosage , Cytarabine*/adverse effects , Cytarabine*/therapeutic use , Central Nervous System Neoplasms*/drug therapy , Central Nervous System Neoplasms*/mortality , Consolidation Chemotherapy*/methods , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Female ; Male ; Aged ; Retrospective Studies ; Middle Aged ; Aged, 80 and over ; Treatment Outcome ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Lymphoma, Large B-Cell, Diffuse/mortality

المؤلفون: Schlenk RF; Department of Internal Medicine V, Heidelberg University Hospital; NCT-Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg. richard.schlenk@nct-heidelberg.de.

المصدر: Haematologica [Haematologica] 2024 Jun 01; Vol. 109 (6), pp. 1629-1630. Date of Electronic Publication: 2024 Jun 01.

نوع المنشور: Letter; Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Cytarabine*/therapeutic use , Cytarabine*/administration & dosage , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/drug therapy , Consolidation Chemotherapy*, Humans ; Male ; Female ; Middle Aged ; Antimetabolites, Antineoplastic/therapeutic use ; Antimetabolites, Antineoplastic/administration & dosage ; Prognosis ; Adult ; Aged ; Biomarkers, Tumor/genetics ; Treatment Outcome

المؤلفون: Fulati W; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Ma J; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Wu M; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Qian W; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Chen P; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Hu Y; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Chen M; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Xu Y; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Huang Z; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Zhang H; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Xie Y; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Shen L; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 May 10; Vol. 15, pp. 1382189. Date of Electronic Publication: 2024 May 10 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, T-Cell, Peripheral*/therapy , Lymphoma, T-Cell, Peripheral*/mortality , Transplantation, Autologous* , Hematopoietic Stem Cell Transplantation*/adverse effects , Consolidation Chemotherapy* , Induction Chemotherapy*, Humans ; Female ; Male ; Middle Aged ; Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Remission Induction ; Aged ; Retrospective Studies ; Young Adult ; Treatment Outcome ; Prognosis ; Combined Modality Therapy

المؤلفون: Zeng Q; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Tang Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Zhou HT; Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Li N; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Liu WY; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Chen SL; Department of Radiation Oncology, Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies), Fuzhou 350001, China., Li S; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China., Lu NN; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Fang H; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Wang SL; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Liu YP; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Song YW; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Li YX; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Jin J; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China.

المصدر: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Apr 23; Vol. 46 (4), pp. 335-343.

نوع المنشور: Journal Article; Clinical Trial, Phase III; English Abstract

بيانات الدورية: Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium: Print ISSN: 0253-3766 (Print) Linking ISSN: 02533766 NLM ISO Abbreviation: Zhonghua Zhong Liu Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: Rectal Neoplasms*/pathology , Rectal Neoplasms*/therapy , Neoadjuvant Therapy* , Consolidation Chemotherapy*, Humans ; Chemotherapy, Adjuvant ; Prognosis ; Disease-Free Survival ; Proportional Hazards Models ; Male ; Female ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Middle Aged ; Survival Rate ; Rectum

المؤلفون: Bauer PS; Department of Surgery, Section of Colon & Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Gamboa AC; Division of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Otegbeye EE; Department of Surgery, Section of Colon & Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Chapman WC; Department of Surgery, Section of Colon & Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Rivard S; Department of Surgery, Division of Colorectal Surgery, University of Michigan, Ann Arbor, Michigan, USA., Regenbogen S; Department of Surgery, Division of Colorectal Surgery, University of Michigan, Ann Arbor, Michigan, USA., Mohammed M; Department of Surgery, University of Pittsburgh Medical Center, Division of Colon and Rectal Surgery, Pittsburgh, Pennsylvania, USA., Holder-Murray J; Department of Surgery, University of Pittsburgh Medical Center, Division of Colon and Rectal Surgery, Pittsburgh, Pennsylvania, USA., Wiseman JT; Department of Surgery, Division of Surgical Oncology, The Ohio State University, Columbus, Ohio, USA., Ejaz A; Department of Surgery, Division of Surgical Oncology, The Ohio State University, Columbus, Ohio, USA., Edwards-Hollingsworth K; Section of Colon & Rectal Surgery, Vanderbilt University Medical Center, Division of General Surgery, Nashville, Tennessee, USA., Hawkins AT; Section of Colon & Rectal Surgery, Vanderbilt University Medical Center, Division of General Surgery, Nashville, Tennessee, USA., Hunt SR; Department of Surgery, Section of Colon & Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Balch G; Department of Surgery, Division of Colon & Rectal Surgery, Emory University, Atlanta, Georgia, USA., Silviera ML; Department of Surgery, Section of Colon & Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

المصدر: Journal of surgical oncology [J Surg Oncol] 2024 Feb; Vol. 129 (2), pp. 254-263. Date of Electronic Publication: 2023 Oct 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Consolidation Chemotherapy* , Rectal Neoplasms*/therapy , Rectal Neoplasms*/pathology, Humans ; Retrospective Studies ; Chemoradiotherapy/adverse effects ; Neoadjuvant Therapy/adverse effects ; Neoplasm Staging

المؤلفون: Masuda K; Division of Respiratory Medicine, Clinical Department of Internal Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan., Nagai Y; Division of Respiratory Medicine, Clinical Department of Internal Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan., Amari H; Division of Respiratory Medicine, Clinical Department of Internal Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan., Tahara H; Division of Respiratory Medicine, Clinical Department of Internal Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan., Maeda Y; Division of Respiratory Medicine, Clinical Department of Internal Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan., Shiihara J; Division of Respiratory Medicine, Clinical Department of Internal Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan., Ohta H; Division of Respiratory Medicine, Clinical Department of Internal Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan., Hiruta M; Department of Pathology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Yamaguchi Y; Division of Respiratory Medicine, Clinical Department of Internal Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.

المصدر: Thoracic cancer [Thorac Cancer] 2023 Nov; Vol. 14 (31), pp. 3161-3165. Date of Electronic Publication: 2023 Sep 12.

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-7714 (Electronic) Linking ISSN: 17597706 NLM ISO Abbreviation: Thorac Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Consolidation Chemotherapy* , Lung Neoplasms*/drug therapy, Aged ; Female ; Humans ; Antibodies, Monoclonal/therapeutic use ; Chemoradiotherapy ; Disease Progression

المؤلفون: Vailati BB; Colorectal surgery division, Angelita and Joaquim Gama Institute, São Paulo, Brazil.; Department of Coloproctology, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.; Department of Surgical Oncology, Hospital Beneficencia Portuguesa, São Paulo, Brazil., Cerdán-Santacruz C; Department of Surgical Oncology, Hospital de la Princesa, Madrid, Spain., São Julião GP; Colorectal surgery division, Angelita and Joaquim Gama Institute, São Paulo, Brazil.; Department of Coloproctology, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.; Department of Surgical Oncology, Hospital Beneficencia Portuguesa, São Paulo, Brazil., Corbi L; Colorectal surgery division, Angelita and Joaquim Gama Institute, São Paulo, Brazil.; Department of Coloproctology, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil., Perez RO; Colorectal surgery division, Angelita and Joaquim Gama Institute, São Paulo, Brazil.; Department of Coloproctology, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.; Department of Surgical Oncology, Hospital Beneficencia Portuguesa, São Paulo, Brazil.

المصدر: Diseases of the colon and rectum [Dis Colon Rectum] 2023 Oct 01; Vol. 66 (10), pp. 1297-1299. Date of Electronic Publication: 2023 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Country of Publication: United States NLM ID: 0372764 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0358 (Electronic) Linking ISSN: 00123706 NLM ISO Abbreviation: Dis Colon Rectum Subsets: MEDLINE

مواضيع طبية MeSH: Consolidation Chemotherapy* , Rectal Neoplasms*/radiotherapy , Rectal Neoplasms*/drug therapy, Humans ; Fluorouracil/therapeutic use ; Neoadjuvant Therapy ; Chemoradiotherapy

المؤلفون: Pratz KW; Department of Medicine, Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Cherry M; Morristown Medical Center, Carol G. Simon Cancer Center, Morristown, NJ., Altman JK; Department of Medicine, Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Cooper BW; University Hospitals, Cleveland Medical Center, Cleveland, OH., Podoltsev NA; Yale School of Medicine, New Haven, CT., Cruz JC; Methodist Hospital, San Antonio, TX., Lin TL; University of Kansas Medical Center, Kansas City, KS., Schiller GJ; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA., Jurcic JG; Columbia University Medical Center, New York, NY., Asch A; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK., Wu R; Astellas Pharma Global Development, Northbrook, IL., Hill JE; Astellas Pharma Global Development, Northbrook, IL., Gill SC; Astellas Pharma Global Development, Northbrook, IL., James AJ; Astellas Pharma Global Development, Northbrook, IL., Rich ES; Astellas Pharma Global Development, Northbrook, IL., Hasabou N; Astellas Pharma Global Development, Northbrook, IL., Perl AE; Department of Medicine, Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Levis MJ; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Sep 10; Vol. 41 (26), pp. 4236-4246. Date of Electronic Publication: 2023 Jun 28.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Consolidation Chemotherapy* , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Adult ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Idarubicin ; Protein Kinase Inhibitors/therapeutic use ; fms-Like Tyrosine Kinase 3/genetics ; Mutation

المؤلفون: Lv XY; Department of Hematology, The First Hospital of Lanzhou University, Lanzhou, Gansu Province, China.; Department of Hematology and Oncology, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China., Li ZJ; Department of Hematology, The First Hospital of Lanzhou University, Lanzhou, Gansu Province, China. ldyy_lizj@lzu.edu.cn.

المصدر: Annals of hematology [Ann Hematol] 2023 Jul; Vol. 102 (7), pp. 1739-1744. Date of Electronic Publication: 2023 May 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Factor XIII*/analysis , Consolidation Chemotherapy*/adverse effects , Leukemia, Myeloid, Acute*/blood , Leukemia, Myeloid, Acute*/drug therapy , Factor XIII Deficiency*/blood , Factor XIII Deficiency*/chemically induced , Thrombocytopenia*/blood , Thrombocytopenia*/chemically induced, Remission Induction ; Humans ; Male ; Female ; Child, Preschool ; Child ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged